Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic review-Reference-Cited by-同舟云学术

Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic review

Published:2022-08 Issue: Volume:176 Page:103747
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Waisberg Federico,Lopez Carlos,Enrico Diego,Rodriguez Andrés,Hirsch Ian,Burton Jeannette,Mandó Pablo,Martin Claudio,Chacón Matias,Seetharamu Nagashree

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference31 articles.

1. Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy;Bylicki;Ann. Oncol.,2015

2. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension;Calvert;JAMA,2013

3. The functional assessment of cancer therapy scale: development and validation of the general measure;Cella;J. Clin. Oncol. Off J. Am. Soc. Clin. Oncol.,1993

4. Cochrane Handbook for Systematic Reviews of Interventions [Internet]. [cited 2021 Dec 20];Available from: 〈https://handbook-5–1.cochrane.org/〉.

5. Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies;D’Antonio;Ther. Adv. Med. Oncol.,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding health-related quality of life measures used in early-stage non-small cell lung cancer clinical trials: A review;Lung Cancer;2024-01

2. Perspectives of patients with advanced or metastatic non-small cell lung cancer on symptoms, impacts on daily activities, and thresholds for meaningful change: a qualitative research study;Frontiers in Psychology;2023-09-08

3. HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks;OncoTargets and Therapy;2023-02